Schedule 13D ownership disclosure
Accelerate Diagnostics, Inc
Security class unavailable · CUSIP: 00430H102
Event date: 2016-02-09
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 14,106,565
- Percent of class
- 27.5000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001144204-16-084310
- Form type
- SC 13D
- Filer
- Accelerate Diagnostics, Inc
- CIK
- CIK 727207
- Filed
- Feb 25, 2016
- Reporting period
- Feb 09, 2016
- Description
- Schedule 13D beneficial ownership